Disarm Therapeutics, a new biotechnology company developing therapeutics to treat patients with neurological diseases by preventing axonal degeneration, today announced the recent completion of a $30 million Series A financing. The round was led b...
WUSTL Faculty and Staff Promote your discoveries and creations
Search WUSTL technologies
Engage with WUSTL Startups and find resources to get you on your journey!
Participate in technology discussions through programs, seminars and workshops
No events found for this month
The roots of chronic itching have long remained a mystery. Meanwhile, those with the condition suffer from an unrelenting and sometimes debilitating urge to scratch. Now, new research at Washington University School of Medicine in St. Louis has id...
Since he was a graduate student, Washington University in St. Louis systems engineer Jr-Shin Li has provided specific mathematical information to experimentalists and clinicians who need it to perform high-resolution magnetic resonance application...